Kim YH - Search Results

1

Efficacy of RCI001 as a Therapeutic Candidate in a Primary Sjögren Syndrome Mouse Model.

Kang H, Jung YH, Moon J, Ryu JS, Yoon CH, Kim YH, Kim MK, Kim DH. Kang H, et al. Among authors: kim yh, kim dh, kim mk. Cornea. 2025 Feb 1;44(2):226-233. doi: 10.1097/ICO.0000000000003696. Epub 2024 Dec 26. Cornea. 2025. PMID: 39288434 Free PMC article.

2

Experimental Models, Induction Protocols, and Measured Parameters in Dry Eye Disease: Focusing on Practical Implications for Experimental Research.

Rahman MM, Kim DH, Park CK, Kim YH. Rahman MM, et al. Among authors: kim yh, kim dh. Int J Mol Sci. 2021 Nov 9;22(22):12102. doi: 10.3390/ijms222212102. Int J Mol Sci. 2021. PMID: 34830010 Free PMC article. Review.

3

Investigating the Anti-Inflammatory Effects of RCI001 for Treating Ocular Surface Diseases: Insight Into the Mechanism of Action.

Kim S, Jang YW, Ku YA, Shin Y, Rahman MM, Chung MH, Kim YH, Kim DH. Kim S, et al. Among authors: kim yh, kim dh. Front Immunol. 2022 Mar 24;13:850287. doi: 10.3389/fimmu.2022.850287. eCollection 2022. Front Immunol. 2022. PMID: 35401555 Free PMC article.

4

Ocular Distribution and Pharmacokinetics of 8-Oxo-2'-Deoxyguanosine: A Novel Therapeutic Candidate of Ocular Surface Diseases.

Chung H, Ha Y, Kim YH, Kim DH, Shin D. Chung H, et al. Among authors: kim yh, kim dh. J Ocul Pharmacol Ther. 2022 Oct;38(8):561-566. doi: 10.1089/jop.2022.0054. J Ocul Pharmacol Ther. 2022. PMID: 36288559

5

Comparison of RCI001 and corticosteroid on the effects on intraocular pressure in mice.

Kim SH, Ku YA, Yoo C, Kim YH, Kim DH. Kim SH, et al. Among authors: kim yh, kim dh. Front Med (Lausanne). 2023 Oct 9;10:1256569. doi: 10.3389/fmed.2023.1256569. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37877019 Free PMC article.

6

Efficacy of RCI001 as a therapeutic candidate of dry eye disease in a modified mixed dry eye model.

Jung YH, Ku YA, Moon J, Kim S, Ryu JS, Yoon CH, Chung MH, Kim YH, Kim MK, Kim DH. Jung YH, et al. Among authors: kim yh, kim dh, kim s, kim mk. Eye Vis (Lond). 2024 Jun 1;11(1):19. doi: 10.1186/s40662-024-00388-z. Eye Vis (Lond). 2024. PMID: 38822444 Free PMC article.

7

Diosgenin Exerts Analgesic Effects by Antagonizing the Selective Inhibition of Transient Receptor Potential Vanilloid 1 in a Mouse Model of Neuropathic Pain.

Rahman MM, Jo HJ, Park CK, Kim YH. Rahman MM, et al. Among authors: kim yh. Int J Mol Sci. 2022 Dec 13;23(24):15854. doi: 10.3390/ijms232415854. Int J Mol Sci. 2022. PMID: 36555495 Free PMC article.

8

Irisin alleviates CFA-induced inflammatory pain by modulating macrophage polarization and spinal glial cell activation.

Rahman MM, Hwang SM, Go EJ, Kim YH, Park CK. Rahman MM, et al. Among authors: kim yh. Biomed Pharmacother. 2024 Sep;178:117157. doi: 10.1016/j.biopha.2024.117157. Epub 2024 Jul 22. Biomed Pharmacother. 2024. PMID: 39042964 Free article.

9

Riboflavin Inhibits Histamine-Dependent Itch by Modulating Transient Receptor Potential Vanilloid 1 (TRPV1).

Lee K, Choi YI, Im ST, Hwang SM, Lee HK, Im JZ, Kim YH, Jung SJ, Park CK. Lee K, et al. Among authors: kim yh. Front Mol Neurosci. 2021 Jun 18;14:643483. doi: 10.3389/fnmol.2021.643483. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34220447 Free PMC article.

10

The Parkinson's disease DJ-1/PARK7 gene controls peripheral neuronal excitability and painful neuropathy.

Lee SH, Tonello R, Lee K, Roh J, Prudente AS, Kim YH, Park CK, Berta T. Lee SH, et al. Among authors: kim yh. Brain. 2024 Nov 2:awae341. doi: 10.1093/brain/awae341. Online ahead of print. Brain. 2024. PMID: 39486088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,846 results

Search Page

Filters